Nivolumab plus ipilimumab does not improve survival in post-nephrectomy patients with renal cell carcinoma
1. Disease-free survival in the placebo group was 50.7 months and was never reached in the intervention group; however, there ...
1. Disease-free survival in the placebo group was 50.7 months and was never reached in the intervention group; however, there ...
1. In a group of patients undergoing endoscopic removal of symptomatic kidney stones, concurrent removal of asymptomatic stones significantly reduced ...
Effect of a novel online group-coaching program to reduce burnout in female resident physicians: A randomized clinical trial 1. Online ...
Effect of Perioperative Patient Education via Animated Videos in Patients Undergoing Head and Neck Surgery 1. In a cohort of ...
1. Ipatasertib-abiraterone treatment significantly improved progression-free survival compared to placebo-abiraterone in patients with PTEN-loss metastatic castration-resistant prostate cancer. 2. Grade 3 ...
1. Ipatasertib-abiraterone treatment significantly improved progression-free survival compared to placebo-abiraterone in patients with PTEN-loss metastatic castration-resistant prostate cancer. 2. Grade ...
1. Among men with symptoms of overactive bladder with or without concomitant benign prostatic hyperplasia, tamsulosin therapy significantly reduced the ...
An exploratory analysis of tamsulosin for Overactive Bladder (OAB) in men with varying voiding symptom burden 1. Among men with ...
1. Patients continuing perioperative anticoagulation when undergoing robot-assisted radical prostatectomy did not experience an increased incidence of high-grade bleeding. Evidence ...
1. Men diagnosed with localized prostate cancer have lower self-reported quality of life outcomes, particularly sexual function in those who ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.